TheEdgeResearch
Home / Stocks / IWINF

Irwin Naturals Inc. (IWINF)

OTC Healthcare Medical - Pharmaceuticals
$0.50 ▲ +51.52%
Market Cap
$1.7M
Sector
Healthcare
Industry
Medical - Pharmaceuticals
Beta
-0.10
52-Wk Range
0.05-1.07
CEO
Klee Irwin
Country
US
Currency
USD

Irwin Naturals Inc. operates in the Medical - Pharmaceuticals industry of the Healthcare sector, headquartered in Los Angeles, CA, US. The stock last traded at $0.50, up 51.52% on the session, giving a market capitalisation of $1.7M. On trailing twelve-month figures it carries a trailing P/E of -0.18, a net margin of -4.5%. Its beta of -0.10 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
-0.18
Price / Sales
0.02
Price / Book
0.03
EV / EBITDA
14.50
Gross margin
45.5%
Operating margin
2.1%
Net margin
-4.5%
Return on equity
—
Debt / equity
0.92
Current ratio
1.24
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
—
IPO date
2021-10-21
Headquarters
Los Angeles, CA, US
About Irwin Naturals Inc.

Headquartered in Los Angeles, California, Irwin Naturals Inc. operates as a herbal supplement provider, primarily focusing on the distribution of CBD products. Its merchandise is available to consumers worldwide, accessible through its online platforms and an extensive network of approximately 100,000 retail stores. The company previously traded under the name Datinvest International Ltd.

Comparable companies

Irwin Naturals Inc. is most often compared with the following Healthcare names:

ACNNFCANBCBDNFETRGFGABLFKALONUTTQPARNFRCMWSILFF
More research on IWINF
IWINF technical analysis IWINF TheEdge Score Compare against peers
Open full interactive analysis & DCF →